Table of Contents Table of Contents
Previous Page  198 / 264 Next Page
Information
Show Menu
Previous Page 198 / 264 Next Page
Page Background

available substrates (

Fig. 7

). However, it is important to note that cranial nerve palsy

can occur after embolization utilizing liquid and small particle agents such as

Onyx.

19

Thus, preoperative patient counseling regarding the potential risks and ben-

efits of embolization is warranted. Furthermore, a careful preoperative cranial nerve

examination after embolization and immediately before surgery should be performed.

Surgery

Historically, microsurgery with gross total resection was considered the treatment

strategy of choice for JP. Although gross total resection is possible in the majority

of cases, it may result in debilitating cranial neuropathy and less commonly, vascular

injury. In a study done by Sanna and colleagues,

21

53 patients with Fisch class C or D

JP were treated surgically. Gross total resection was achieved in 83% of cases, with a

10% tumor recurrence rate. The presence of new cranial neuropathy varied depending

on the presence of intracranial extension, but was as high as 39%. Recently, the same

group retrospectively reviewed 122 class C or D tumors. Gross tumor control was

achieved in 86% of JPs, though 54% of the patients developed a postoperative lower

cranial nerve injury. Cranial nerve IX was most commonly affected at last follow-up.

22

In another study including 119 patients, nearly 75% of patients had tumor control with

surgical management, and new cranial neuropathies were noted in approximately

50% of patients after surgery.

23

Lastly, Fayad and colleagues,

3

examined the House

Ear Clinic experience with glomus jugulare tumors (GJT), reporting total tumor removal

in 81% of surgical cases. In this series, the incidence of postoperative cranial neurop-

athy varied according to tumor size. For patients with Fisch classification C4 and

lower, the incidence of new cranial nerve injury varied from 8.7% to 13%, whereas

for patients with classification of C4 and higher, the deficit ranged from 63.6% to

81.8%. Overall, 26.5% of patients in this series developed tumor recurrence at an

average of 26 months.

In an effort to minimize morbidity and improve symptoms associated with disease,

subtotal resection has been used with increasing frequency by many centers. Subtotal

resection may be particularly relevant to older or infirm patients with advanced disease

Fig. 6.

Glomus jugulare as seen on a contrast-enhanced MRI scan. The arrow designates the

tumor with a characteristic salt-and-pepper appearance. (

A

) is an axial cut; (

B

) is a coronal

cut.

Wanna et al

177